Bill · H.R. 7237· House(119-HR-7237)
Chemical Abortion Risk Awareness Act
- Introduced
- 1/23/2026
- Last activity
- 1/23/2026 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Marlin Stutzman
- Cosponsors
- - 2 - 0
- Introduced
- In Committee
What this bill would do
The Chemical Abortion Risk Awareness Act aims to amend the Public Health Service Act. It seeks to ensure that women undergoing a chemical abortion are informed of the risks involved. The bill requires providers who receive Federal funds to provide specific drug labeling and read highlighted warning sections to the woman. These requirements must be met at least 24 hours before the procedure. The Act also establishes a framework for implementation plans and potential withholding of Federal funding for non-compliance. Additionally, it creates a private right of action for women or their parents.
Yes
Would women be better off under this?+3
The bill ensures women receive highlighted warnings and verbal disclosures regarding the risks of chemical abortion drugs.
Does this make what the government does easier for the public to see?+2
The bill requires providers to submit implementation plans to the Secretary of Health and Human Services.
The opposite
Does this make abortion easier to get?-5
The mandate for specific disclosures and the threat of withholding federal funds create barriers to obtaining chemical abortions.
Does this make health care easier to get in general?-3
The bill imposes significant legal and financial risks for providers, which may limit access to abortion services.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Information for Patients: Under Section 3402(b), providers must provide a full FDA-approved product label with highlighted 'Warnings and Precautions' and 'Adverse Reactions' sections. This ensures the woman receives specific information regarding the drugs being used.
-
Verbal Disclosure of Risks: Section 3402(b)(2) requires the provider to read the highlighted sections of the drug label to the woman, which could ensure the risks are clearly communicated.
-
Legal Recourse for Violations: Section 3404(a) allows a woman or her parent to commence a civil action against a provider who violates the requirements of this title, providing a way to seek relief for non-compliance.
Potential Negative Impacts for People
-
Financial Burden on Providers and Entities: Section 3402(a) applies to providers or companies receiving Federal funds, and Section 3403 allows the Secretary to withhold Federal funding if they are not in compliance, which could impact their operations.
-
Legal and Financial Risks for Providers: Under Section 3404(b), providers could be liable for objectively verifiable money damages for physical or psychological injuries, statutory damages equal to three times the cost of the abortion, and punitive damages.
-
Potential Costs for Litigants: While the bill protects women from being assessed damages, Section 3404(d) states that if a defendant prevails and the court finds a suit was frivolous, the court shall award a reasonable attorney's fee to the defendant.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Abortion Access-5Improves Healthcare Access-3
- Demographic And Interest Groups
- Good For Women+3
- Governance And Ideology
- Improves Government Transparency+2
- 9/2/2026
- 1 Cosponsor added.
- 1/23/2026
- Referred to the House Committee on Energy and Commerce.
- 1 Cosponsor added.
- Introduced in House
Andrew ClydeRepublican · Georgia
Diana HarshbargerRepublican · Tennessee